The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Saflutan 15 micrograms/ml eye drops, solution

Santen OYPA0879/008/001

Main Information

Trade NameSaflutan 15 micrograms/ml eye drops, solution
Active SubstancesTafluprost
Dosage FormEye drops, solution
Licence HolderSanten OY
Licence NumberPA0879/008/001

Group Information

ATC CodeS01EE05 tafluprost


Licence Issued15/02/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back